CellRapeutics™ Leukopak from Psoriasis Donor (XS-0426-XU259)

Name: CellRapeutics™ Leukopak from Psoriasis Donor
SKU: XS-0426-XU259
Rating: 5 (1 reviews)

Online Inquiry Datasheet

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Harvested from donors with Psoriasis Vulgaris, this Leukopak captures the systemic immune landscape of chronic plaque-type dermatosis. The collection is characterized by a significant expansion of the IL-23/IL-17 axis and circulating skin-homing T cells. This product is optimized for large-scale studies on the systemic comorbidities of psoriasis and the evaluation of the immune-modulatory effects of systemic biologics on the peripheral leucocyte compartment.

Specific Inquiry

Add to Cart

Donor Information

Product Name
CellRapeutics™ Leukopak from Psoriasis Donor

Cat. No.
XS-0426-XU259

Donor Age
Young Adult, Middle-Aged

Donor Health
Clinically diagnosed with chronic plaque Psoriasis. The leukocyte profile is marked by a significant Th17/Th1 cytokine bias and expanded populations of skin-homing T cells and activated dendritic cells.

Ethnicity
Diverse backgrounds available.

Anticoagulant
Acid Citrate Dextrose, prioritized to stabilize the IL-17/IL-23 axis-related T cell populations and maintain their functional potency.

Additional Donor Information
Each lot features a Leukopak from donors with plaque psoriasis. Profiles include PASI scores and affected body surface area, supporting studies on the Th17/IL-23 axis in peripheral blood.

Clinical Profile
Clinical subtype, PASI score, percentage of Body Surface Area affected, and history of systemic or biologic therapy.

Additional Information

Medication History
Available upon request. Documentation of topical agents, systemic methotrexate or retinoids, and history of biologics targeting TNF, IL-17, or IL-23.

Formulation
Cryopreserved or Fresh options available.

Cell Purity
>90%

Cell Viability
>90%

Mycoplasma Testing
Negative

Sterility Testing
Negative

Genetic Stability Testing
The donor cells maintain their native genetic profile, exhibiting no karyotypic abnormalities or chromosomal instabilities typically associated with prolonged ex vivo expansion.

Application
Drug Discovery, Immuno-oncology Research

Research Use Only
RUO

Quality Control
Each product batch is strictly validated for high cellular viability, specific immune cell counts, and pathogen-free safety, ensuring consistent clinical phenotypes and ethical compliance for advanced immunological research.

Storage
Store fresh Leukopaks at 2°C to 8°C for immediate use, cryopreserved samples must be kept in liquid nitrogen vapor phase below -150°C.

Shiping
Dry Ice

Handling Notes
Process fresh cells within 48 hours or perform rapid thawing of cryovials in a 37°C water bath followed by gradual dilution to maximize recovery.

Warnings
Treat as potentially biohazardous human-derived material and handle strictly under BSL-2 guidelines using appropriate personal protective equipment.

Size
Full Bag, Half Bag

Keywords
CellRapeutics™ Leukopak from Psoriasis Donor, Leukopak, Psoriasis

Case Studies

Customer Reviews and Q&As

There are currently no customer reviews or questions for CellRapeutics™ Leukopak from Psoriasis Donor (XS-0426-XU259). Click the button below to contact us or submit your feedback about this product.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.